Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
NCT00747578 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2008-09-08
Summary
Ankylosing spondylitis (AS), rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are the most common rheumatic diseases dealt with rheumatologists in Taiwan. In previous studies, the 3 diseases all have broad impacts on health-related quality of life of patients and drive enormous economic burden on patients and society. The objective of this study is to compare health-related quality of life and disease-related costs between patients with the 3 different diseases.
We will invite at least 100 patients with AS, RA or SLE respectively who are regularly followed in the outpatient clinic of the Division of Rheumatology at Taichung Veterans General Hospital (VGHTC) to participate in the study. Patients who have cognitive impairment, who are older than 65 years old or younger than 18 years old, who have overlapping syndrome of any 2 of the 3 rheumatic diseases (eg. RA overlapping with SLE) or who have visited rheumatologists in the outpatient clinics at VGHTC for less than 4 times in 2008 will be excluded. Patients who agree to take part will attend a comprehensive clinical examination in the outpatient department. Patients will complete a questionaire including demographic and disease characteristics, and health-related quality of life at the time of survey. The questionaires about disease-related costs will be completed once per quarter throughout 2009. The four questionaires about costs will be given at the time of initial survey and will be returned by returned by mail or in the following outpatient clinics visits every 3 months in 2009.
The result of this study will help patients to realize their own health-related quality of life and disease-related costs and help government in Taiwan to realize the socioeconomic burden of the 3 common rheumatic diseases and to allocate health care resources more properly in the future.
Conditions
Sponsors & Collaborators
-
Taichung Veterans General Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
Countries
- Taiwan
Study Locations
More Related Trials
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.
NCT07069972 ·Status: NOT_YET_RECRUITING
-
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy
NCT04976465 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus
NCT05179018 ·Status: UNKNOWN
-
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage
NCT05045417 ·Status: UNKNOWN
-
Rheumatology Patient Registry and Biorepository
NCT04402086 ·Status: RECRUITING
-
This Project Aims to Understand the Needs of Rheumatologists and Other Specialties in the Care of Patients With SLE
NCT06698900 ·Status: COMPLETED
-
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
NCT07000916 ·Status: RECRUITING
-
Tear Proteins, Conjunctival Cells and Imaging Eyes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients
NCT02217137 ·Status: COMPLETED
-
Pulmonary Disease Among Patients With Systemic Lupus Erythematosus
NCT06087523 ·Status: ENROLLING_BY_INVITATION
-
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus
NCT03179046 ·Status: COMPLETED
-
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
NCT01172002 ·Status: UNKNOWN ·Phase: NA
-
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases
NCT04276701 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients
NCT04266860 ·Status: COMPLETED ·Phase: NA
-
Anemia in Systemic Lupus Erythematosus Specially Refractory Type
NCT06210295 ·Status: NOT_YET_RECRUITING
-
Scrutinizing the Heterogeneity of SLE: Defining Phenotypes
NCT03348774 ·Status: UNKNOWN
-
Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)
NCT03878303 ·Status: UNKNOWN ·Phase: PHASE1
-
Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
NCT06610422 ·Status: NOT_YET_RECRUITING
-
The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
NCT02435368 ·Status: UNKNOWN
-
The Role of Some Hematological Parameters in Juvenile Systemic Lupue Erythematosus
NCT06227559 ·Status: NOT_YET_RECRUITING
-
Auto-immune Diseases and Quality of Life
NCT02855840 ·Status: COMPLETED
-
A Comparative Study of the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus Involving Multiple Units, Based on Previous Data.
NCT07053137 ·Status: ACTIVE_NOT_RECRUITING
-
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
NCT06294483 ·Status: ENROLLING_BY_INVITATION
-
Premature Atherosclerosis in Systemic Lupus Erythematosus
NCT04037293 ·Status: UNKNOWN